Clinical trials recruiting for pMMR/MSS Advanced Colorectal Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| High dose MSH2-/- tumor cell vaccine | 1 |
| Low Dose MSH2-/- tumor cell vaccine | 1 |
| Medium Dose MSH2-/- tumor cell vaccine | 1 |
| chidamide, regorafenib, and iparomlimab/tuvonralimab | 1 |
Self-screener
Recruiting trials
- Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
- The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
Related conditions
Trials recruiting for pMMR/MSS Advanced Colorectal Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for pMMR/MSS Advanced Colorectal Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.